Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Vaccine advertising - patient vs DTC
-
Hello,
PAAB distinguishes patients from consumers based on whether they have been prescribed/have received a product or not. Does the same logic apply to vaccines?
- Would a branded APS promoting the vaccine (to people who haven't received it yet) be considered a DTC piece, and therefore allowed to be promotional within the scope of the Health Canada "The Distinction Between Advertising and Other Activities" guidance? Does this change depending on placement of APS (eg, social media ad vs HCP waiting room poster)
- What would constitute a "patient" piece when it comes to vaccines? Would it only be materials given to patients after they have received the vaccine? And would such a piece need to be non-promotional like all other patient materials for pharmaceuticals or are they treated differently since vaccines are Schedule D?
-
Hello @supraja
A patient is someone who the decision has been made by an HCP to place them on the product. For vaccines, such pieces can be promotional, and per PAAB code section 6 it would be subject to PAAB preclearance if an HCP is involved in distribution of the material.
-
@jennifer-carroll ok that clarifies things, thank you very much!
